2011～2013年南京地区胰岛素及胰岛素类似物应用情况分析

目的:评价南京地区2011~2013年胰岛素及胰岛素类似物的临床应用情况和变化趋势。方法:对南京地区43家医院2011~2013年胰岛素及胰岛素类似物的品种、销售金额、用药频度(DDDs)等进行统计和分析。结果:胰岛素及胰岛素类似物的使用总金额逐年增长,平均年增长率16%。甘精胰岛素、精蛋白生物合成人胰岛素(预混30R)、门冬胰岛素30、生物合成人胰岛素、门冬胰岛素等5个品种3年均排在金额排序的前5位,且所占比例均超过80%。而精蛋白生物合成人胰岛素(预混30R)、门冬胰岛素30、甘精胰岛素、生物合成人胰岛素、普通胰岛素等5个品种3年均排在DDDs值排序的前5位。结论:南京地区胰岛素及胰岛素类似物临床应用广泛,使用量和金额均呈快速增长趋势。

Clinical Application Analysis of Insulin and Its Analogs in Hospitals of Nanjing during 2011-2013

ABSTRACT Objective: To evaluate the application status and change trends of insulin and its analogs in Nanjing area during 2011 to 2013. Methods: The varieties, sales amount and DDDs of insulin and its analogs in 43 hospitals of Nanjing during 2011 to 2013 were analyzed.Results:The use of insulin and its analogs was increased year by year from 2011 to 2013 with the average annual growth rate of 16%. Glargine, pre mixed insulin 30R,aspart 30, human insulin and aspart ranked the top five in the sum of money with the proportion above 80%. Pre mixed insulin 30R,aspart 30,glargine, human insulin and common insulin ranked the top 5 in DDDs.Conclusion:The application of insulin and its analogs is wide in clinics, and the usage and sum of money both show rapid growth trend.